Journal of Medicinal Chemistry · 2001 · 77 citations · 6 references
PharmacyMedicinal ChemistryPharmacologyChemotherapyDrug DeliveryDrug DiscoveryAnticancer Prodrug DesignDrug DispositionMolecular Mechanisms Of ToxicityPh-activated ProdrugsPharmacokinetics Of Anticancer DrugsTumor-activated ProdrugsChemotherapeutic Prodrug DesignPharmacokinetics Of Ph-activated ProdrugsPhysiological Ph EffectsProdrug Toxicity EvaluationTumor Microenvironment-activated ProdrugsTumor-microenvironment Activated ProdrugsTumor-targeted Ph-activated ProdrugsTumor-targeted Prodrugs
Intravenous administration of N-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin (4) induces an acute toxic reaction, killing animals in a few minutes. This results from its positive charge at physiological pH combined with its propensity to form large aggregates in aqueous solutions. Negatively charged N-capped versions of 4 such as the succinyl derivative 5 can be administered by the iv route at more than 10 times the LD(50) of doxorubicin without inducing the acute toxic reaction, and they are active in vivo.
6
Cancer chemotherapy and biotherapy: Principles and practice
L.E. Ellis · Surgical Oncology · 1997 · 423 citations
Medicine, Oncology, Pharmacotherapy +12
Jan C. Horrow · Anesthesia & Analgesia · 1985 · 287 citations
Medicine, Cardiology, Pharmacology +16
Achintya K. Sinhababu, Dhiren R. Thakker · Advanced Drug Delivery Reviews · 1996 · 105 citations